Publications by authors named "Linus M Risser"

Claim this Profile
[
[Renewed increase in new Janus kinase inhibitor prescriptions : Analysis of the German RHADAR registry].
Patrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, Torsten Witte, Matthias Fröhlich

Z Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cells of patients with systemic sclerosis or Sjögren's disease display an aberrant metabolic state and memory phenotype in blood and lungs.
Christine Ehlers, Hannah Biermann, Thea Thiele, Jonas C Schupp, Matteo Villa, Linus M Risser

Rheumatology (Oxford)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.
Linus Maximilian Risser, Torsten Witte, Matthias Englbrecht, Patrick-Pascal Strunz, Matthias Froehlich

Rheumatol Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network.
Patrick-Pascal Strunz, Matthias Englbrecht, Linus Maximilian Risser, Torsten Witte, Matthias Froehlich

Rheumatol Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective study.
Patrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, Torsten Witte, Matthias Froehlich

Front Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database.
Patrick-Pascal Strunz, Matthias Englbrecht, Linus Maximilian Risser, Torsten Witte, Matthias Froehlich

Front Immunol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis.
Ignatius Ryan Adriawan, Faranaz Atschekzei, Oliver Dittrich-Breiholz, Panagiotis Garantziotis, Stefanie Hirsch, Linus Maximillian Risser

Ann Rheum Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis